LDL receptor deficiency unmasks altered VLDL triglyceride metabolism in VLDL receptor transgenic and knockout mice

This publication has 24 references indexed in Scilit:

• An Extrahepatic Receptor-associated Protein-sensitive Mechanism Is Involved in the Metabolism of Triglyceride-rich Lipoproteins
  Journal of Biological Chemistry, 1999
• Hyperlipidemia and cutaneous abnormalities in transgenic mice overexpressing human apolipoprotein C1.
  Journal of Clinical Investigation, 1998
• Dietary Regulation of the Very Low Density Lipoprotein Receptor in Mouse Heart and Fat
  Hormone and Metabolic Research, 1997
• In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway.
  Journal of Clinical Investigation, 1996
• Reversal of Hypercholesterolemia in Low Density Lipoprotein Receptor Knockout Mice by Adenovirus-mediated Gene Transfer of the Very Low Density Lipoprotein Receptor
  Journal of Biological Chemistry, 1996
• Expression of the VLDL Receptor in Endothelial Cells
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1996
• The Very Low Density Lipoprotein Receptor Mediates the Cellular Catabolism of Lipoprotein Lipase and Urokinase-Plasminogen Activator Inhibitor Type I Complexes
  Published by Elsevier ,1995
• Targeting gene expression to the vascular wall in transgenic mice using the murine preproendothelin-1 promoter.
  Journal of Clinical Investigation, 1995
• Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery.
  Journal of Clinical Investigation, 1993
• Heparan sulphate proteoglycans are involved in the lipoprotein lipase-mediated enhancement of the cellular binding of very low density and low density lipoproteins
  Biochemical and Biophysical Research Communications, 1992